BioSpace News Archive

Biotech Beach

Eos Biosciences Announces Issuance of Additional U.S. Patent For Targeted Breast Cancer Therapy

Eos Biosciencess announced that the U.S. Patent and Trademark Office has now issued Eos Biosciences a second patent, U.S. Patent No. 9,789,201, for Eos-001, the company’s HER3-targeted Eosome with doxorubicin payload.

October 17, 2017

·

2 min read

Biotech Bay

UZ Leuven Treats First Patient in Europe on Varian Halcyon Cancer Treatment System

Variantoday announced an 80-year-old male with head & neck cancer became the first patient in Europe to be treated on the Halcyon system at University Hospitals Leuven in Belgium.

October 17, 2017

·

2 min read

Business

Circuit Clinical And ePatientFinder Partner To Create Largest Research Site Network In U.S.

ePatientFinder announced a partnership that will create the largest and highest-performing clinical research site network in the U.S. Together the two companies serve more than 200 clinical sites.

October 17, 2017

·

4 min read

Lone Star Bio

EOSERA Wins TechFW IMPACT Award

Eosera, Inc. announced today that it has been named a winner of the 2017 Tech Fort Worth IMPACT Awards.

October 17, 2017

·

3 min read

Business

Genfit Completes a 180M Euro Offering of Bonds Convertible Into New Shares and/or Exchangeable for Existing Shares (“Oceanes”) Due 2022

Following strong demand from investors - the Offering was multiple times overscribed - the initial amount of the Offering was increased from 150 to 180 million euros.

October 17, 2017

·

12 min read

Drug Development

AntriaBio Announces Selection of Lead Oral Plasma Kallikrein Inhibitor Candidates for the Treatment of Diabetic Retinopathy, Diabetic Macular Edema and Hereditary Angioedema

The two preclinical programs are AB402 for vision-threatening eye complications of diabetes including Diabetic Retinopathy and Diabetic Macular Edema, and AB602, which is being developed to treat Hereditary Angioedema.

October 17, 2017

·

5 min read

Business

Intricon To Announce 2017 Third-Quarter Results On Monday, November 6

IntriCon Corporation announced that it will release its 2017 third-quarter results on Monday, November 6, 2017, at market close.

October 17, 2017

·

1 min read

Biotech Beach

As Patent Expires, AHF Calls on Gilead for 90% Price Reduction on Tenofovir-based Drugs, Including Truvada

AIDS Healthcare Foundation (AHF), the largest global AIDS organization and a vocal critic of runaway drug pricing and drug profiteering, today called on Gilead Sciences, Inc. to reduce the price of its tenofovir-based drug regimens-including Truvada-by as much as 90%.

October 17, 2017

·

5 min read

Desktop Genetics Introduces New Series Of Customizable CRISPR Libraries

Desktop Genetics Ltd announced the launch of its DESKGEN Series CRISPR Libraries to support gene editing efforts in academic and biopharma settings.

October 17, 2017

·

3 min read

The Netherlands Cancer Institute Awarded Funding To Apply Molecular Imaging Technology To Prostate Cancer Surgery

The Netherlands Cancer Institute (NKI) announced today that it has received funding from the Dutch Cancer Society (KWF Kankerbestrijding) to test whether a novel molecular imaging technology can guide prostate cancer surgery.

October 17, 2017

·

3 min read